Peter Palese, Ph.D., Horace W. Goldsmith Professor and Chair, Microbiology, Professor, Department of Medicine, Icahn School of Medicine at Mount Sinai
Michael T. Osterholm, Ph.D., MPH, Director, Center for Infectious Disease Research and Policy (CIDRAP), and Professor, Environmental Health Sciences, School of Public Health, University of Minnesota
John Tsang, Ph.D., Chief, Systems Genomics and Bioinformatics Unit, LSB, and Head, Computational Systems Biology, Trans-NIH Center for Human Immunology (CHI), NAIAD-NIH
Each year, ImVacS brings vaccine professionals together from around the world to discuss the crucial issues surrounding vaccine development. Along with presenting a snapshot of where vaccines stand today, the meeting also provides an important venue for networking, information exchange, and establishing collaborations.
The “Novel Vaccines” meeting explores how vaccine development is being innovated in order to create more efficacious vaccines, such as using Systems Biology or Reverse Vaccinology. The use of adjuvants – their safety and mode of action – will also be discussed, as will DNA vaccines, Toll-Like Receptors, and novel modes of delivery. In addition, how improved vaccines are targeting infectious diseases will be addressed and updated.